RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13 , 330.
Shiwei ZhouObinna N ObianomJiangsheng HuangDong GuoHong YangQing LiYan ShuPublished in: Pharmaceutics (2023)
The authors and the journal retract the article, 'Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation' [...].